Global Top Three Trade Places As Going Gets Tough, Especially In The US

 
• By Aidan Fry

Mylan has moved up to become the world’s leading generics, biosimilars and OTC player, according to Generics Bulletin’s newly compiled global rankings. Sandoz has surpassed troubled Teva into second spot, but is set to surrender that position once it sells its US solid-dose and dermatology business to India’s Aurobindo, which has already moved into the global top 10.

123
The three leading generics, biosimilars and OTC players globally traded places last year as they focused more on boosting their bottom lines than striving for sales growth • Source: Shutterstock

More from Earnings

More from Business